Ligand validation:6OWY

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OWY_IMD_A_212	78%	78%	0.125	0.967	0.4	0.49	-	-	0	0	100%	1
6OWY_IMD_B_203	62%	70%	0.165	0.958	0.56	0.58	-	-	0	0	100%	1
6OWY_IMD_A_213	55%	71%	0.186	0.955	0.52	0.6	-	-	0	0	100%	1
6BIE_IMD_A_216	93%	75%	0.088	0.983	0.37	0.59	-	-	0	0	100%	1
5WO1_IMD_B_204	90%	72%	0.108	0.993	0.35	0.73	-	-	1	0	100%	0.86
5WO3_IMD_B_201	90%	76%	0.087	0.971	0.38	0.55	-	-	0	0	100%	1
5WNW_IMD_B_201	71%	74%	0.145	0.966	0.47	0.55	-	-	1	0	100%	1
5WO2_IMD_B_204	66%	64%	0.113	0.917	0.7	0.68	-	-	1	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
9FP4_IMD_A_402	100%	74%	0.036	0.993	0.23	0.76	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.